Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Maintenance Of The Response To Sacral Pulsed Radiofrequency In Chronic Prostatitis/Pelvic Pain Syndrome Using Hyperbaric Oxygen

Gallego-Vilar D, Cuñat Albert E and Gallego-Gomez J

Introduction: None of treatments reported for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has shown considerable improvement in patient´s daily life. Our objective is to determine the efficacy of hyperbaric oxygen therapy (HBOT) in the maintenance of response after sacral pulsed radiofrequency (PRF) in patients with CP/CPPS.

Material and methods: Prospective, comparative study including men with CP/CPPS divided in group A: S2-S4 PRF; and group B: S2-S4 PRF+HBO. The evaluated variables were pain (through the visual analog scale, VAS), and quality of life using the The NIH Chronic Prostatitis Symptom Index (CPSI) at 0, 1, 3, 6 and 12 months-follow up. Responders were predefined as patients who had experienced a more than 50% of decrease in the total NIH- CPSI score and more than 50% improvement in different areas of KHQ.

Results: 24 patients met the inclusion/exclusion criteria (17 Group A; 7 Group B) . A significant manteinance of improvement (p<0.05) for pain subscore, urinary subscore, quality of life subscore, total NIH-CPSI score and all the areas of KHQ was noticed in Group B after 18 months follow-up. No adverse effects were reported.

Conclusions: In this study, HBO improved the maintenance of the beneficial effects of sacral PRF among men with CP/CPPS.